aluates Reports

$ 0.0

Automative

Global Pharmaceutical CRDMO Service Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-38U13934

Global Pharmaceutical CRDMO Service Market Research Report 2023

BUY CHAPTERS

Global Pharmaceutical CRDMO Service Market Research Report 2025

Code: QYRE-Auto-38U13934

Report

May 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bioduro-Sundia

Sai Life Sciences

Icosagen

Wuxi Biologics

WuXi AppTec

Esco Aster

Jubilant Biosys

Syngene International

Ardena Holding

Eurofins

Jiangsu HUAYI Technology Co., Ltd.

Chemveda

Pharmaceutical CRDMO Service Market Size

The global market for Pharmaceutical CRDMO Service was valued at US$ 93.4 million in the year 2024 and is projected to reach a revised size of US$ 147 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Pharmaceutical CRDMO Service Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CRDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CRDMO Service.

The Pharmaceutical CRDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical CRDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical CRDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical CRDMO Service Market Report

Report Metric	Details
Report Name	Pharmaceutical CRDMO Service Market
Accounted market size in year	US$ 93.4 million
Forecasted market size in 2031	US$ 147 million
CAGR	6.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Small Molecule CRDMO Service Middle Molecule CRDMO Service Large Molecule CRDMO Service
Segment by Application	Oncology Infectious Disease Neurology Immunology Hematology Vaccine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioDuro-Sundia, Sai Life Sciences, Icosagen, WuXi Biologics, WuXi AppTec, Esco Aster, Jubilant Biosys, Syngene International, Chemveda, Ardena Holding, Eurofins, Jiangsu HUAYI Technology Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CRDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical CRDMO Service Market growing?

Ans: The Pharmaceutical CRDMO Service Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Pharmaceutical CRDMO Service Market size in 2031?

Ans: The Pharmaceutical CRDMO Service Market size in 2031 will be US$ 147 million.

Who are the main players in the Pharmaceutical CRDMO Service Market report?

Ans: The main players in the Pharmaceutical CRDMO Service Market are BioDuro-Sundia, Sai Life Sciences, Icosagen, WuXi Biologics, WuXi AppTec, Esco Aster, Jubilant Biosys, Syngene International, Chemveda, Ardena Holding, Eurofins, Jiangsu HUAYI Technology Co., Ltd.

What are the Application segmentation covered in the Pharmaceutical CRDMO Service Market report?

Ans: The Applications covered in the Pharmaceutical CRDMO Service Market report are Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccine, Others

What are the Type segmentation covered in the Pharmaceutical CRDMO Service Market report?

Ans: The Types covered in the Pharmaceutical CRDMO Service Market report are Small Molecule CRDMO Service, Middle Molecule CRDMO Service, Large Molecule CRDMO Service

Recommended Reports

Drug Development Services

Disease Treatment Drugs

Pharmaceutical Consulting & Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical CRDMO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Small Molecule CRDMO Service

1.2.3 Middle Molecule CRDMO Service

1.2.4 Large Molecule CRDMO Service

1.3 Market by Application

1.3.1 Global Pharmaceutical CRDMO Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Infectious Disease

1.3.4 Neurology

1.3.5 Immunology

1.3.6 Hematology

1.3.7 Vaccine

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical CRDMO Service Market Perspective (2020-2031)

2.2 Global Pharmaceutical CRDMO Service Growth Trends by Region

2.2.1 Global Pharmaceutical CRDMO Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical CRDMO Service Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical CRDMO Service Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical CRDMO Service Market Dynamics

2.3.1 Pharmaceutical CRDMO Service Industry Trends

2.3.2 Pharmaceutical CRDMO Service Market Drivers

2.3.3 Pharmaceutical CRDMO Service Market Challenges

2.3.4 Pharmaceutical CRDMO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical CRDMO Service Players by Revenue

3.1.1 Global Top Pharmaceutical CRDMO Service Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical CRDMO Service Revenue Market Share by Players (2020-2025)

3.2 Global Pharmaceutical CRDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical CRDMO Service Revenue

3.4 Global Pharmaceutical CRDMO Service Market Concentration Ratio

3.4.1 Global Pharmaceutical CRDMO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CRDMO Service Revenue in 2024

3.5 Global Key Players of Pharmaceutical CRDMO Service Head office and Area Served

3.6 Global Key Players of Pharmaceutical CRDMO Service, Product and Application

3.7 Global Key Players of Pharmaceutical CRDMO Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CRDMO Service Breakdown Data by Type

4.1 Global Pharmaceutical CRDMO Service Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical CRDMO Service Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical CRDMO Service Breakdown Data by Application

5.1 Global Pharmaceutical CRDMO Service Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical CRDMO Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical CRDMO Service Market Size (2020-2031)

6.2 North America Pharmaceutical CRDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical CRDMO Service Market Size by Country (2020-2025)

6.4 North America Pharmaceutical CRDMO Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical CRDMO Service Market Size (2020-2031)

7.2 Europe Pharmaceutical CRDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical CRDMO Service Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical CRDMO Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical CRDMO Service Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical CRDMO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical CRDMO Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical CRDMO Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutical CRDMO Service Market Size (2020-2031)

9.2 Latin America Pharmaceutical CRDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical CRDMO Service Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical CRDMO Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical CRDMO Service Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical CRDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical CRDMO Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical CRDMO Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioDuro-Sundia

11.1.1 BioDuro-Sundia Company Details

11.1.2 BioDuro-Sundia Business Overview

11.1.3 BioDuro-Sundia Pharmaceutical CRDMO Service Introduction

11.1.4 BioDuro-Sundia Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.1.5 BioDuro-Sundia Recent Development

11.2 Sai Life Sciences

11.2.1 Sai Life Sciences Company Details

11.2.2 Sai Life Sciences Business Overview

11.2.3 Sai Life Sciences Pharmaceutical CRDMO Service Introduction

11.2.4 Sai Life Sciences Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.2.5 Sai Life Sciences Recent Development

11.3 Icosagen

11.3.1 Icosagen Company Details

11.3.2 Icosagen Business Overview

11.3.3 Icosagen Pharmaceutical CRDMO Service Introduction

11.3.4 Icosagen Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.3.5 Icosagen Recent Development

11.4 WuXi Biologics

11.4.1 WuXi Biologics Company Details

11.4.2 WuXi Biologics Business Overview

11.4.3 WuXi Biologics Pharmaceutical CRDMO Service Introduction

11.4.4 WuXi Biologics Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.4.5 WuXi Biologics Recent Development

11.5 WuXi AppTec

11.5.1 WuXi AppTec Company Details

11.5.2 WuXi AppTec Business Overview

11.5.3 WuXi AppTec Pharmaceutical CRDMO Service Introduction

11.5.4 WuXi AppTec Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.5.5 WuXi AppTec Recent Development

11.6 Esco Aster

11.6.1 Esco Aster Company Details

11.6.2 Esco Aster Business Overview

11.6.3 Esco Aster Pharmaceutical CRDMO Service Introduction

11.6.4 Esco Aster Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.6.5 Esco Aster Recent Development

11.7 Jubilant Biosys

11.7.1 Jubilant Biosys Company Details

11.7.2 Jubilant Biosys Business Overview

11.7.3 Jubilant Biosys Pharmaceutical CRDMO Service Introduction

11.7.4 Jubilant Biosys Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.7.5 Jubilant Biosys Recent Development

11.8 Syngene International

11.8.1 Syngene International Company Details

11.8.2 Syngene International Business Overview

11.8.3 Syngene International Pharmaceutical CRDMO Service Introduction

11.8.4 Syngene International Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.8.5 Syngene International Recent Development

11.9 Chemveda

11.9.1 Chemveda Company Details

11.9.2 Chemveda Business Overview

11.9.3 Chemveda Pharmaceutical CRDMO Service Introduction

11.9.4 Chemveda Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.9.5 Chemveda Recent Development

11.10 Ardena Holding

11.10.1 Ardena Holding Company Details

11.10.2 Ardena Holding Business Overview

11.10.3 Ardena Holding Pharmaceutical CRDMO Service Introduction

11.10.4 Ardena Holding Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.10.5 Ardena Holding Recent Development

11.11 Eurofins

11.11.1 Eurofins Company Details

11.11.2 Eurofins Business Overview

11.11.3 Eurofins Pharmaceutical CRDMO Service Introduction

11.11.4 Eurofins Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.11.5 Eurofins Recent Development

11.12 Jiangsu HUAYI Technology Co., Ltd.

11.12.1 Jiangsu HUAYI Technology Co., Ltd. Company Details

11.12.2 Jiangsu HUAYI Technology Co., Ltd. Business Overview

11.12.3 Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Introduction

11.12.4 Jiangsu HUAYI Technology Co., Ltd. Revenue in Pharmaceutical CRDMO Service Business (2020-2025)

11.12.5 Jiangsu HUAYI Technology Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bioduro-Sundia

Sai Life Sciences

Icosagen

Wuxi Biologics

WuXi AppTec

Esco Aster

Jubilant Biosys

Syngene International

Ardena Holding

Eurofins

Jiangsu HUAYI Technology Co., Ltd.

Chemveda

List of Tables

Table 1. Global Pharmaceutical CRDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Small Molecule CRDMO Service

Table 3. Key Players of Middle Molecule CRDMO Service

Table 4. Key Players of Large Molecule CRDMO Service

Table 5. Global Pharmaceutical CRDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Pharmaceutical CRDMO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pharmaceutical CRDMO Service Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Pharmaceutical CRDMO Service Market Share by Region (2020-2025)

Table 9. Global Pharmaceutical CRDMO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Pharmaceutical CRDMO Service Market Share by Region (2026-2031)

Table 11. Pharmaceutical CRDMO Service Market Trends

Table 12. Pharmaceutical CRDMO Service Market Drivers

Table 13. Pharmaceutical CRDMO Service Market Challenges

Table 14. Pharmaceutical CRDMO Service Market Restraints

Table 15. Global Pharmaceutical CRDMO Service Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Pharmaceutical CRDMO Service Market Share by Players (2020-2025)

Table 17. Global Top Pharmaceutical CRDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CRDMO Service as of 2024)

Table 18. Ranking of Global Top Pharmaceutical CRDMO Service Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Pharmaceutical CRDMO Service Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Pharmaceutical CRDMO Service, Headquarters and Area Served

Table 21. Global Key Players of Pharmaceutical CRDMO Service, Product and Application

Table 22. Global Key Players of Pharmaceutical CRDMO Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharmaceutical CRDMO Service Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Pharmaceutical CRDMO Service Revenue Market Share by Type (2020-2025)

Table 26. Global Pharmaceutical CRDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Pharmaceutical CRDMO Service Revenue Market Share by Type (2026-2031)

Table 28. Global Pharmaceutical CRDMO Service Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Pharmaceutical CRDMO Service Revenue Market Share by Application (2020-2025)

Table 30. Global Pharmaceutical CRDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Pharmaceutical CRDMO Service Revenue Market Share by Application (2026-2031)

Table 32. North America Pharmaceutical CRDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Pharmaceutical CRDMO Service Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Pharmaceutical CRDMO Service Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Pharmaceutical CRDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Pharmaceutical CRDMO Service Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Pharmaceutical CRDMO Service Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Pharmaceutical CRDMO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Pharmaceutical CRDMO Service Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Pharmaceutical CRDMO Service Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Pharmaceutical CRDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Pharmaceutical CRDMO Service Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Pharmaceutical CRDMO Service Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Pharmaceutical CRDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Pharmaceutical CRDMO Service Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Pharmaceutical CRDMO Service Market Size by Country (2026-2031) & (US$ Million)

Table 47. BioDuro-Sundia Company Details

Table 48. BioDuro-Sundia Business Overview

Table 49. BioDuro-Sundia Pharmaceutical CRDMO Service Product

Table 50. BioDuro-Sundia Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 51. BioDuro-Sundia Recent Development

Table 52. Sai Life Sciences Company Details

Table 53. Sai Life Sciences Business Overview

Table 54. Sai Life Sciences Pharmaceutical CRDMO Service Product

Table 55. Sai Life Sciences Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 56. Sai Life Sciences Recent Development

Table 57. Icosagen Company Details

Table 58. Icosagen Business Overview

Table 59. Icosagen Pharmaceutical CRDMO Service Product

Table 60. Icosagen Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 61. Icosagen Recent Development

Table 62. WuXi Biologics Company Details

Table 63. WuXi Biologics Business Overview

Table 64. WuXi Biologics Pharmaceutical CRDMO Service Product

Table 65. WuXi Biologics Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 66. WuXi Biologics Recent Development

Table 67. WuXi AppTec Company Details

Table 68. WuXi AppTec Business Overview

Table 69. WuXi AppTec Pharmaceutical CRDMO Service Product

Table 70. WuXi AppTec Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 71. WuXi AppTec Recent Development

Table 72. Esco Aster Company Details

Table 73. Esco Aster Business Overview

Table 74. Esco Aster Pharmaceutical CRDMO Service Product

Table 75. Esco Aster Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 76. Esco Aster Recent Development

Table 77. Jubilant Biosys Company Details

Table 78. Jubilant Biosys Business Overview

Table 79. Jubilant Biosys Pharmaceutical CRDMO Service Product

Table 80. Jubilant Biosys Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 81. Jubilant Biosys Recent Development

Table 82. Syngene International Company Details

Table 83. Syngene International Business Overview

Table 84. Syngene International Pharmaceutical CRDMO Service Product

Table 85. Syngene International Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 86. Syngene International Recent Development

Table 87. Chemveda Company Details

Table 88. Chemveda Business Overview

Table 89. Chemveda Pharmaceutical CRDMO Service Product

Table 90. Chemveda Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 91. Chemveda Recent Development

Table 92. Ardena Holding Company Details

Table 93. Ardena Holding Business Overview

Table 94. Ardena Holding Pharmaceutical CRDMO Service Product

Table 95. Ardena Holding Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 96. Ardena Holding Recent Development

Table 97. Eurofins Company Details

Table 98. Eurofins Business Overview

Table 99. Eurofins Pharmaceutical CRDMO Service Product

Table 100. Eurofins Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 101. Eurofins Recent Development

Table 102. Jiangsu HUAYI Technology Co., Ltd. Company Details

Table 103. Jiangsu HUAYI Technology Co., Ltd. Business Overview

Table 104. Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Product

Table 105. Jiangsu HUAYI Technology Co., Ltd. Revenue in Pharmaceutical CRDMO Service Business (2020-2025) & (US$ Million)

Table 106. Jiangsu HUAYI Technology Co., Ltd. Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical CRDMO Service Picture

Figure 2. Global Pharmaceutical CRDMO Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical CRDMO Service Market Share by Type: 2024 VS 2031

Figure 4. Small Molecule CRDMO Service Features

Figure 5. Middle Molecule CRDMO Service Features

Figure 6. Large Molecule CRDMO Service Features

Figure 7. Global Pharmaceutical CRDMO Service Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Pharmaceutical CRDMO Service Market Share by Application: 2024 VS 2031

Figure 9. Oncology Case Studies

Figure 10. Infectious Disease Case Studies

Figure 11. Neurology Case Studies

Figure 12. Immunology Case Studies

Figure 13. Hematology Case Studies

Figure 14. Vaccine Case Studies

Figure 15. Others Case Studies

Figure 16. Pharmaceutical CRDMO Service Report Years Considered

Figure 17. Global Pharmaceutical CRDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Pharmaceutical CRDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Pharmaceutical CRDMO Service Market Share by Region: 2024 VS 2031

Figure 20. Global Pharmaceutical CRDMO Service Market Share by Players in 2024

Figure 21. Global Top Pharmaceutical CRDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CRDMO Service as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Pharmaceutical CRDMO Service Revenue in 2024

Figure 23. North America Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Pharmaceutical CRDMO Service Market Share by Country (2020-2031)

Figure 25. United States Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Pharmaceutical CRDMO Service Market Share by Country (2020-2031)

Figure 29. Germany Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Pharmaceutical CRDMO Service Market Share by Region (2020-2031)

Figure 37. China Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Pharmaceutical CRDMO Service Market Share by Country (2020-2031)

Figure 45. Mexico Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Pharmaceutical CRDMO Service Market Share by Country (2020-2031)

Figure 49. Turkey Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Pharmaceutical CRDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. BioDuro-Sundia Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 53. Sai Life Sciences Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 54. Icosagen Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 55. WuXi Biologics Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 56. WuXi AppTec Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 57. Esco Aster Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 58. Jubilant Biosys Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 59. Syngene International Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 60. Chemveda Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 61. Ardena Holding Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 62. Eurofins Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 63. Jiangsu HUAYI Technology Co., Ltd. Revenue Growth Rate in Pharmaceutical CRDMO Service Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharma Contract Service Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CGT Drugs Market Research Report 2025

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Asset Managements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Treatment Planning Software Market Research Report 2025

Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Discovery CRO Market Research Report 2025

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Global Drugs of Abuse Testing Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions